Učitavanje...
Cognitive and Antipsychotic Medication Use in Monoallelic GBA-Related Parkinson Disease
Mutations in glucosidase, beta, acid (GBA) are associated with cognitive impairment in Parkinson disease (PD) as well as dementia with Lewy bodies. For both of these diseases, dementia and hallucinations are typically treated with cholinesterase inhibitors and antipsychotics. However, in some lysoso...
Spremljeno u:
| Izdano u: | JIMD Rep |
|---|---|
| Glavni autori: | , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer Berlin Heidelberg
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4221612/ https://ncbi.nlm.nih.gov/pubmed/24850235 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/8904_2014_315 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|